October 26, 2017 / 5:45 AM / 7 months ago

BRIEF-Gensight Biologics: cash and cash equivalents position at Sept 30 at EUR 59.5​ million

Oct 26 (Reuters) - GENSIGHT BIOLOGICS SA:

* ‍CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 59.5 MILLION AS OF SEPTEMBER 30, 2017, COMPARED TO EUR 63.6 MILLION AS OF JUNE 30, 2017.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below